On February 28, 2023, the company received $1,700,000 in its first tranche. The transaction included participation from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd. and Huons Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,700 KRW | -0.44% | -0.59% | -12.24% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
65,700 KRW | +0.61% | +0.77% | 422M | ||
33,700 KRW | -0.44% | -0.59% | 296M | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.24% | 296M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- A243070 Stock
- News Huons Co., Ltd.
- GenEdit Inc. amended terms of the transaction